Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Edland

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Journal of Molecular Neuroscience : MN|June 8, 2004
Insulin-degrading enzyme, apolipoprotein E, and Alzheimer's diseaseSteven D Edland
The International Journal of Biostatistics|February 13, 2021
Power formulas for mixed effects models with random slope and intercept comparing rate of change across groupsYu Zhao, Steven D Edland
Nature Medicine|October 13, 2011
Fractional synthesis and clearance rates for amyloid βSteven D Edland, Douglas R Galasko
Journal of Alzheimer'S Disease : JAD|October 6, 2011
Power calculations for clinical trials in Alzheimer's diseaseM Colin Ard, Steven D Edland
International Journal of Statistics in Medical Research|January 25, 2021
Power Calculations for Two-Wave, Change from Baseline to Follow-up Study DesignsM Colin Ard, Steven D Edland
Statistics in Medicine|January 13, 2004
Genetic association studies in Alzheimer's disease research: challenges and opportunitiesSteven D Edland, Susan Slager, Matthew Farrer
International Journal of Statistics in Medical Research|February 2, 2018
The MAX Statistic is Less Powerful for Genome Wide Association Studies Under Most Alternative HypothesesBenjamin Shifflett, Rong Huang, Steven D Edland
Neurology|August 29, 2023
Semorinemab in Mild-to-Moderate Alzheimer Disease: A Glimmer of Hope Though Cautions RemainSteven D Edland, Jorge J Llibre-Guerra
Pharmaceutical Statistics|March 10, 2020
Counterpoint to Jin et al, On weighted composite scores for early Alzheimer's trials. Pharm Stat. 18 (2):239-47, 2019, DOI: 10.1002/pst.1920Steven D Edland, Nandini Raghavan, M Colin Ard
Journal of the American Geriatrics Society|June 19, 2013
Exploratory study of apolipoprotein E ε4 genotype and risk of Alzheimer's disease in Mexican HispanicsMelissa Campos, Steven D Edland, Guerry M Peavy
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Journal of Molecular Neuroscience : MN|June 8, 2004
Insulin-degrading enzyme, apolipoprotein E, and Alzheimer's diseaseSteven D Edland
The International Journal of Biostatistics|February 13, 2021
Power formulas for mixed effects models with random slope and intercept comparing rate of change across groupsYu Zhao, Steven D Edland
Nature Medicine|October 13, 2011
Fractional synthesis and clearance rates for amyloid βSteven D Edland, Douglas R Galasko
Journal of Alzheimer'S Disease : JAD|October 6, 2011
Power calculations for clinical trials in Alzheimer's diseaseM Colin Ard, Steven D Edland
International Journal of Statistics in Medical Research|January 25, 2021
Power Calculations for Two-Wave, Change from Baseline to Follow-up Study DesignsM Colin Ard, Steven D Edland
Statistics in Medicine|January 13, 2004
Genetic association studies in Alzheimer's disease research: challenges and opportunitiesSteven D Edland, Susan Slager, Matthew Farrer
International Journal of Statistics in Medical Research|February 2, 2018
The MAX Statistic is Less Powerful for Genome Wide Association Studies Under Most Alternative HypothesesBenjamin Shifflett, Rong Huang, Steven D Edland
Neurology|August 29, 2023
Semorinemab in Mild-to-Moderate Alzheimer Disease: A Glimmer of Hope Though Cautions RemainSteven D Edland, Jorge J Llibre-Guerra
Pharmaceutical Statistics|March 10, 2020
Counterpoint to Jin et al, On weighted composite scores for early Alzheimer's trials. Pharm Stat. 18 (2):239-47, 2019, DOI: 10.1002/pst.1920Steven D Edland, Nandini Raghavan, M Colin Ard
Journal of the American Geriatrics Society|June 19, 2013
Exploratory study of apolipoprotein E ε4 genotype and risk of Alzheimer's disease in Mexican HispanicsMelissa Campos, Steven D Edland, Guerry M Peavy
Pageof 10